Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

Mayne Pharma Group Ltd (MYX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
7.120 +0.290    +4.25%
02:04:59 - Closed. Currency in AUD ( Disclaimer )
Type:  Equity
Market:  Australia
ISIN:  AU000000MYX0 
  • Volume: 186,868
  • Bid/Ask: 7.050 / 7.120
  • Day's Range: 6.850 - 7.180
Mayne Pharma 7.120 +0.290 +4.25%

MYX Balance Sheet

 
Featured here, the Balance Sheet for Mayne Pharma Group Ltd, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Current Assets 475.3 475.3 553.63 553.63
Cash and Short Term Investments 154.81 154.81 220.14 220.14
Cash - - - -
Cash & Equivalents 109.23 109.23 92.62 92.62
Short Term Investments 45.58 45.58 127.53 127.53
Total Receivables, Net 198.86 198.86 209.52 209.52
Accounts Receivables - Trade, Net 171.24 171.24 177.4 177.4
Total Inventory 91.9 91.9 82.7 82.7
Prepaid Expenses - - 13.1 13.1
Other Current Assets, Total 29.72 29.72 28.17 28.17
Total Assets 1152.65 1152.65 1247.35 1247.35
Property/Plant/Equipment, Total - Net 50.35 50.35 51.48 51.48
Property/Plant/Equipment, Total - Gross 92.41 92.41 103.81 103.81
Accumulated Depreciation, Total -42.05 -42.05 -52.32 -52.32
Goodwill, Net - - - -
Intangibles, Net 584.64 584.64 615.22 615.22
Long Term Investments - - - -
Note Receivable - Long Term 27.62 27.62 32.12 32.12
Other Long Term Assets, Total 15.48 15.48 2.32 2.32
Other Assets, Total -4.78 -4.78 53.58 53.58
Total Current Liabilities 295.66 295.66 310.96 310.96
Accounts Payable 42.77 42.77 32.03 32.03
Payable/Accrued - - - -
Accrued Expenses 180.12 180.12 195.87 195.87
Notes Payable/Short Term Debt - - 10.81 10.81
Current Port. of LT Debt/Capital Leases 3.47 3.47 3.62 3.62
Other Current liabilities, Total 69.3 69.3 68.64 68.64
Total Liabilities 604.88 604.88 612.99 612.99
Total Long Term Debt 33.11 33.11 33.08 33.08
Long Term Debt 30.02 30.02 28.48 28.48
Capital Lease Obligations 3.09 3.09 4.6 4.6
Deferred Income Tax 6.13 6.13 7.8 7.8
Minority Interest - - - -
Other Liabilities, Total 269.98 269.98 250.35 250.35
Total Equity 547.77 547.77 634.36 634.36
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 1223.92 1223.92 1233.69 1233.69
Additional Paid-In Capital - - - -
Retained Earnings (Accumulated Deficit) -840.32 -840.32 -769.77 -769.77
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 164.18 164.18 170.44 170.44
Total Liabilities & Shareholders' Equity 1152.65 1152.65 1247.35 1247.35
Total Common Shares Outstanding 81.25 81.25 83.42 83.42
Total Preferred Shares Outstanding - - - -
* In Millions of AUD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MYX Comments

Write your thoughts about Mayne Pharma Group Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Filip dB
Phildb Jul 26, 2022 2:36AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Mayne Pharma’s CEO Mr Scott Richards said: “We are delighted to introduce NEXTSTELLIS® contraceptive to the Australian market. NEXTSTELLIS® offers an effective, safe, and well-tolerated contraceptive pill with predictable cycle control and has demonstrated low impact on certain parts of the body. The launch will be supported by an expanded national GP/specialist sales team that are now educating healthcare professionals on the unique characteristics of E4.”
HOMAYOUN KHORRAM
HOMAYOUN KHORRAM Mar 24, 2021 12:24AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
time to buy
PAWAN Kumar
PAWAN Kumar Jul 08, 2020 2:47AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Golden cross on the BULL side formed. Every one will jump in now.
PAWAN Kumar
PAWAN Kumar Jul 08, 2020 1:21AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Nice level to get set long term here.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email